Citigroup
PRNB

Citigroup’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Citigroup’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,643
Closed -$1.83M – 7708
2020
Q2 		$1.83M Buy
30,643
+17,645
+136% +$1.09M ﹤0.01% 2908
2020
Q1 		$772K Sell
12,998
-929
-7% -$54.2K ﹤0.01% 3438
2019
Q4 		$763K Buy
13,927
+12,783
+1,117% +$477K ﹤0.01% 4034
2019
Q3 		$32K Sell
1,144
-3,663
-76% -$134K ﹤0.01% 6430
2019
Q2 		$160K Buy
4,807
+3,279
+215% +$102K ﹤0.01% 5458
2019
Q1 		$52K Sell
1,528
-105
-6% -$3.34K ﹤0.01% 6316
2018
Q4 		$45K Buy
+1,633
New +$42.1K ﹤0.01% 6325

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Citigroup's PRNB Position: Q3 2020 in Review

Citigroup sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 30,643 shares — an estimated $1.83M sold.

Citigroup first reported a position in PRNB in Q4 2018 and held it in 7 quarters. The position peaked at $1.83M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Citigroup reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Citigroup sold 30,643 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $1.83M.
  • Citigroup first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 7 quarters.
  • Citigroup's Principia Biopharma Inc. Common Stock position peaked at $1.83M in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Citigroup's 13F filing for Q3 2020, filed 12 Nov 2020.